MERCURIUS™

Full-length DRUG-seq service
for high-throughput transcriptomics

Massively multiplexed and full-length RNA-seq directly on cell, organoid and tissue lysates - no need for prior RNA extraction.

Discover Sample Datasets

Human

Multiplexed full-length mRNA-seq

96 samples in a single tube

Full-length coding transcript coverage

From differential gene expression to splicing variants and isoform detection

No RNA extraction, no material loss

Prepare libraries directly from frozen cell pellets.

Ideal for large
RNA-seq projects

The more samples processed, the lower the cost per sample.

About the service

The MERCURIUS™ Full-Length DRUG-seq service is a convenient and scalable solution for projects of any size, enabling transcriptome-wide detection of full-length coding transcripts.

Users simply deliver their 96-well plates containing frozen cells to us in Switzerland or the United States.

Upon receipt of the plates, our team prepares the libraries, then sequences to your desired read depth per sample, and then performs data pre-processing.

We return results, including raw fastq files, sequencing and alignment reports, and gene count matrices suitable for downstream differential expression analyses, once the data meet our rigorous quality control criteria.

During the process, we always keep clients informed at defined checkpoints so we can decide together how best to proceed to the next steps.

preps in a single tube
Up to 0
genes detected at 1M reads/sample
0 +
extraction steps needed
Down to 0 RNA
library prep workflow
Down to 0 day

1. Uniform detection of 22'000+ genes at 12 million reads per sample across 48 samples

Distribution of the number of detected genes across 48 samples prepared with the MERCURIUS™ Full-Length BRB-seq service. The library was sequenced at an average of 12 million reads.

2. Full-Length BRB-seq shows high demultiplexing rate and high mapping rate to exons

Full-Length BRB-seq performance shows 99% demultiplexing rate from raw data, 78% mapping rate, and 18% duplication rate of the 48 pooled samples and sequenced at 12 million reads per sample.

3. Mapping rates as high as 80% for different RNA inputs

Mapping rates are uniform across three RNA inputs tested: 1ug, 10ng, and 100ng. Human Universal Reference RNA was used to prepare mRNA Full-Length BRB libraries. 

4. Full-Length BRB-seq exhibits reads distribution across the transcript’s entire length

The gene body coverage shows a consistent and uniform reads distribution across the entire gene body for the Full-Length BRB-seq protocol, comparable to competitor N protocol, while the BRB-seq protocol  shows a significant 3′ bias due to its poly-A selection methodology.

5. >50'000 isoforms detected at 12M sequencing depth

Benchmarking the Full-Length BRB-seq protocol against competitor N shows similar performance for isoform detection. More than 50,000 isoforms can be detected at a sequencing depth of 12M reads per sample.

Sample Datasets

Human

Number of samples:
96
Reads per sample in demo dataset:
10'000 reads

To have access to the deep-sequenced dataset contact us.

Demo dataset file size:
238MB

Publications

Multi‐well plate lid for single‐step pooling of 96 samples for high‐throughput barcode‐based sequencing.

Cell-cycle inhibition preserves robust development but rebalances lineages in mouse gastruloids.

Spermidine Reproduces the Anti-Inflammatory Effects of Intermittent Fasting and Prevents Urate and Calcium Pyrophosphate Crystal-Induced Inflammation.

To generate high-quality sequencing data we recommend starting with 5’000 – 25’000 mammalian cells per well for 96 well-plate and 2’000 – 10’000 cells per well for 384 well-plate.

The total RNA amount per pool should be at least 80’000 cells.

MERCURIUS™ DRUG-seq can be performed on various sample types, including: Cell lines, Primary cells, Organoids, or Spheroids.

Check out our DRUG-seq Kits page for a list of our validated cell lines. 

Full-Length DRUG-seq provides comprehensive coverage of the full-length mRNA transcripts.

We, therefore, normally recommend sequencing 5-20 million reads for each sample, depending on project scale and scope.

As part of our standard service pipeline, we align the generated data to the genome of choice, provide a detailed report on the alignment and gene counting statistics and, finally, provide ready-to-use gene count matrices for downstream analysis.
Optionally, we can include differential gene expression analysis.

Ask your question:

Getting started with our MERCURIUS™ Full-length DRUG-seq services is simple

You can either book a call with our experts to discuss your project or submit your experimental details via our contact form so we can review your design and requirements. Based on the goals, sample types, and scale of your study, we may recommend starting with a pilot project to optimise conditions and de-risk a larger screen.

Blog Posts

August 25, 2025

Determining the most suitable transcriptomic technology to drive your large-scale compound screen, clinical study, or to assess a panel of genetic perturbations can be a…

August 25, 2025

High-throughput’ in sequencing refers to the amount of DNA molecules read at the same time. Technologies are now capable of sequencing many fragments of DNA…

May 9, 2025

With a growing number of published 3’ mRNA-seq methods now available, researchers have more choices than ever for high-throughput and cost-effective transcriptomic screening. While broadly…

Interested in ordering MERCURIUS™ RNA-seq kits?